Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the
The UK economic growth faces a paradox of two seemingly opposing pressures, yet both may be resolved by moving in
Dalgety, a UK-based EU-GMP certified medical cannabis cultivator, is pleased to announce a strategic partnership with Curaleaf Laboratories, a trusted name in cannabis medicine and pharmaceutical-quality cannabinoid innovation.
Having done the legwork over the last five years to build a state-of-the-art 30,000sq ft indoor growing facility, and secure licencing to cultivate, manufacture and supply medical cannabis flower from its facility, Dalgety is wasting no time in ramping up its operations.
Written by Ben Stevens and Sarah Sinclair. You can read Part 1 here. Growing demand for medical cannabis across Europe
Dalgety has become one of two leading medical cannabis cultivators in the UK to be granted a Home Office licence to
Tilray [stock_market_widget type=”chart” template=”line” assets=”TLRY” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] US cannabis giant Tilray
Leading UK medical cannabis producer Dalgety has, for the first time, revealed its impressive yield while calling for more industry
We won’t spam you
